July 12, 2019
Nexus Pharmaceuticals Inc., based in Lincolnshire, IL, has reached an agreement with the village of Pleasant Prairie, WI to build a sterile injectable manufacturing facility. The development within the village’s Prairie Highlands Corporate Park will support the production and supply of injectable drugs in an array of therapeutic areas, including anesthesia, oncology, cardiovascular and neurology.
“This is one of the most significant pharmaceutical investments in Wisconsin in years,” said Wisconsin Gov. Tony Evers. “Southeast Wisconsin is increasingly becoming a destination of choice for high-value manufacturing jobs that require a skilled, educated workforce.”
The multi-phase, multi-year project is expected to be completed in 10 years, with an estimated investment of $250 million. The initial phase one investment of $85 million will support a 100,000-square-foot, three-story manufacturing facility, with construction getting underway next month. Pharmaceutical production at the facility is expected to get underway in 2022.
For comments, questions or concerns, please contact Paul Bubny